Ovariectomy upregulates expression of estrogen receptors, NOS, and HSPs in porcine platelets

被引:35
作者
Jayachandran, M [1 ]
Miller, VM [1 ]
机构
[1] Mayo Clin & Mayo Fdn, Dept Surg & Physiol & Biophys, Rochester, MN 55905 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2002年 / 283卷 / 01期
关键词
17; beta-estradiol; hormones; nitric oxide synthase; endothelial nitric oxide synthase; megakaryocytes; inducible nitric oxide synthase; heat shock protein;
D O I
10.1152/ajpheart.00950.2001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Platelets participate in normal and pathological thrombotic processes. Hormone replacement in postmenopausal women is associated with increase risk for thrombosis. However, little is known regarding how platelets are affected by hormonal status. Nitric oxide (NO) modulates platelet functions and is modulated by hormones. Therefore, the present study was designed to determine how loss of ovarian hormones changes expression of estrogen receptors and regulatory proteins for NO synthase (NOS) in platelets. Estrogen receptors (ERalpha and ERbeta), NOS, heat shock proteins 70 and 90 (HSP70 and HSP90), caveolin-1, -2, and -3, calmodulin, NOS activity, and cGMP were analyzed in a lysate of platelets from gonadally intact and ovariectomized female pigs. Expression of ERbeta and ERalpha receptors, endothelial NOS (eNOS), HSP70, and HSP90 increased with ovariectomy. NOS activity and cGMP also increased; calmodulin was unchanged. Caveolins were not detected. These results suggest that ovarian hormones influence expression of estrogen receptors and eNOS in platelets. Changes in estrogen receptors and NOS could affect platelet aggregation in response to hormone replacement.
引用
收藏
页码:H220 / H226
页数:7
相关论文
共 58 条
[51]   Effects of oral combined hormone replacement therapy on platelet aggregation in postmenopausal women [J].
Teede, HJ ;
McGrath, BP ;
Turner, A ;
Majewski, H .
CLINICAL SCIENCE, 2001, 100 (02) :207-213
[52]  
Tonnessen BH, 2000, J PHARMACOL EXP THER, V295, P601
[53]   Mortality and morbidity in transsexual subjects treated with cross-sex hormones [J].
vanKesteren, PJM ;
Asscheman, H ;
Megens, JAJ ;
Gooren, LJG .
CLINICAL ENDOCRINOLOGY, 1997, 47 (03) :337-342
[54]   Hormone replacement therapy and incidence of acute myocardial infarction -: A population-based nested case-control study [J].
Varas-Lorenzo, C ;
García-Rodríguez, LA ;
Perez-Gutthann, S ;
Duque-Oliart, A .
CIRCULATION, 2000, 101 (22) :2572-2578
[55]   Gender and transcriptional regulation of NO synthase and ET-1 in porcine aortic endothelial cells [J].
Wang, XF ;
Barber, DA ;
Lewis, DA ;
McGregor, CGA ;
Sieck, GC ;
Fitzpatrick, LA ;
Miller, VM .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1997, 273 (04) :H1962-H1967
[56]  
WELCH WJ, 1982, J BIOL CHEM, V257, P4949
[57]   Molecular mechanisms of steroid hormone action [J].
White, R ;
Parker, MG .
ENDOCRINE-RELATED CANCER, 1998, 5 (01) :1-14
[58]   Reappraisal of the role of heat shock proteins as regulators of steroid receptor activity [J].
Ylikomi, T ;
Wurtz, JM ;
Syvälä, H ;
Passinen, S ;
Pekki, A ;
Haverinen, M ;
Bläuer, M ;
Tuohimaa, P ;
Gronemeyer, H .
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1998, 33 (06) :437-466